Travere Therapeutics, Inc.

VOYA INVESTMENT MANAGEMENT LLC TVTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

155,895

Value ($000)

5,957

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	5,957	0.0%	155,895	12/31/2025
2025 Q3	10/9/2025	4,657	0.0%	194,854	9/30/2025
2025 Q2	8/14/2025	2,482	0.0%	167,721	6/30/2025
2025 Q1	5/15/2025	2,203	0.0%	122,909	3/31/2025
2024 Q4	5/2/2025	3,478	0.0%	199,672	12/31/2024
2024 Q3	2/7/2025	3,112	0.0%	222,470	9/30/2024
2024 Q2	2/7/2025	205	0.0%	24,942	6/30/2024
2024 Q1	2/7/2025	1,602	0.0%	207,782	3/31/2024
2023 Q4	2/7/2025	264	0.0%	29,380	12/31/2023
2023 Q3	2/7/2025	429	0.0%	47,975	9/30/2023
2023 Q2	2/7/2025	728	0.0%	47,406	6/30/2023
2023 Q1	2/7/2025	945	0.0%	42,017	3/31/2023
2022 Q4	2/7/2025	884	0.0%	42,017	12/31/2022
2022 Q3	2/7/2025	1,068	0.0%	43,347	9/30/2022
2022 Q2	8/15/2022	2,155	0.0%	88,982	6/30/2022
2022 Q1	5/16/2022	604	0.0%	23,422	3/31/2022
2021 Q4	2/14/2022	715	0.0%	23,013	12/31/2021
2021 Q3	11/15/2021	565	0.0%	23,304	9/30/2021
2021 Q2	8/16/2021	341	0.0%	23,324	6/30/2021
2021 Q1	5/17/2021	574	0.0%	23,007	3/31/2021
2020 Q4	2/16/2021	600	0.0%	22,030	12/31/2020